Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000420131 | SCV000528428 | likely benign | not provided | 2020-11-11 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000548494 | SCV000641049 | likely benign | Aortic aneurysm, familial thoracic 4 | 2023-12-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001183481 | SCV000739221 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2016-10-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV001183481 | SCV001349223 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-11-25 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000420131 | SCV002063494 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | MYH11: BP4, BP7 |
Genome Diagnostics Laboratory, |
RCV000420131 | SCV001977707 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000420131 | SCV001980374 | likely benign | not provided | no assertion criteria provided | clinical testing |